ArticleInternational journal of molecular medicine2019

The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.

Li Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.